
Ultra-Processed Food Intake Increases Risk of HF in All Phenotypes
Amier Haidar, MD, MPH, discusses his study of the role UPFs play in causing HFpEF, HFrEF, and HFmrEF, which is mediated by central adiposity.
Higher consumption of ultra-processed food (UPF) is associated with an increased risk of incident
These data were presented at the
“Ultra-processed foods can be an underrecognized risk factor, given that they’re now everywhere,” Haidar told HCPLive. “The majority of people’s diets – over 50% – consist of ultra-processed foods. This shows that that could be an area that we can target to hopefully try and reduce HF risk.”
In 2010, NOVA classified foods into 4 distinct categories in accordance with their level of processing. These included unprocessed or minimally processed foods, processed culinary ingredients, processed foods, and UPFs. This last category is characterized by the presence of substances rarely or never used in kitchens, such as hydrolyzed proteins, soya protein isolate, gluten, casein, whey protein, and so on. Additionally, the presence of additives other than preservatives, such as flavor enhancers, colors, emulsifiers, sweeteners, and thickeners, can identify a food as ultra-processed.2
Using this characterization, Haidar and colleagues collected a sample of 6531 US adults aged 45-84 without cardiovascular disease at baseline, using the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. The team assessed UPF intake with a validated food-frequency questionnaire, classifying these foods according to the NOVA system.1
The team incorporated multivariable Cox proportional hazards models and Fine-Gray competing-risk models to evaluate the associations between UPF intake and incident HF. Phenotypes included HF with reduced or mildly reduced ejection fraction (HFrEF/HFmrEF), characterized as EF <50%, and HF with preserved ejection fraction (HFpEF), with EF ≥50%. Mediation analyses were also conducted to evaluate a possible mediating role for waist-to-height ratio, which served as a surrogate measure for central adiposity.1
During follow-up, a total of 509 incident HF events occurred, of which 236 were HFrEF or HFmrEF, and 194 were HFpEF, with the remaining 70 missing EF data. Haidar and colleagues found that a higher UPF intake was significantly associated with increased HF risk across sequentially adjusted models. In the fully adjusted model, each individual serving of UPF was associated with a 6% greater risk of incident HF (HR, 1.06; 95% CI, 1.01-1.12).1
Patients in the upper 80% of UPF intake had a greater HF risk compared to those in the lower 20% (HR, 1.58; 95% CI, 1.14-2.2). Additionally, after stratifying by phenotype, the team saw that UPF intake was significantly associated with HFpEF (HR, 1.11; 95% CI, 1.02-1.19) but not HFrEF/HFmrEF. Patients in the upper 80% of UPF intake also had a risk of HFpEF over 2-fold higher than those in the lower 20% (HR, 2.23; 95% CI, 1.29-3.87).1
These findings were consistent in Fine-Gray competing-risk models and after excluding patients with myocardial infarction before HF. Additionally, in mediation analysis, Haidar and colleagues saw that waist-to-height ratio mediated roughly 51% of the association between UPF intake and total HF, with a 49% mediation with HFpEF.1
Ultimately, the team concluded that higher UPF consumption was associated directly and significantly with an increased incident HF risk, largely driven by the HFpEF phenotype. Haidar and colleagues noted that these data highlight a need for public health interventions and policy to reduce UPF consumption in an effort to mitigate the ongoing global burden of HF.1
“It’s very hard to do clinical trial research on nutrition in general, so I think appropriate next steps would be looking at defining ultra-processed foods based on other factors, such as hyperpalatability or energy density,” Haidar said. “These types of categories would allow us to differentiate between certain types of food for future trials.”
Editors’ Note: Haidar reports no relevant disclosures.
References
Haidar A, Marupudi A, Rikhi R, et al. Association Between Ultra-Processed Food Consumption and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. Abstract presented at the American Heart Association (AHA) Scientific Sessions 2026, Chicago, IL. November 6-9, 2026.
Levy RB, Barata MF, Leite MA, Andrade GC. How and why ultra-processed foods harm human health. Proc Nutr Soc. 2024 Feb;83(1):1-8.
doi: 10.1017/S0029665123003567
Related to this article








